Literature DB >> 22821334

Late appearance and exacerbation of primary Raynaud's phenomenon attacks can predict future development of connective tissue disease: a retrospective chart review of 3,035 patients.

Slavica Pavlov-Dolijanovic1, Nemanja S Damjanov, Nada Z Vujasinovic Stupar, Goran L Radunovic, Roksanda M Stojanovic, Dragan Babic.   

Abstract

To assess the prognostic value of the age at onset of Raynaud's (RP) and of a history of exacerbation of RP attacks for the development of connective tissue disease (CTD) in patients initially found to have primary Raynaud's. 3,035 patients with primary RP (2,702 women and 333 men) were followed for an average of 4.8 years (range from 1 to 10 years). At baseline and every 6 months, they were screened for signs and symptoms of CTD. At 4.8 years of follow-up, 54.7 % patients remained as primary RP, 8.1 % had developed suspected secondary RP, and 37.2 % had developed a definite CTD. Primary RP patients had an earlier onset of RP (mean age of 32.2 years) than those with suspected (mean age 36.5 years, P = .007) or definite secondary RP associated with CTD (mean age of 39.8 years, P = .004). RP beginning before the age of forty was not significantly associated with the development of CTD. Conversely, the appearance of RP after the age of 40 was significantly associated with the development of CTD (P = .00001). Worsening of RP attacks predicted the development of CTD, especially systemic sclerosis (relative risk [RR] of 1.42), scleroderma overlap syndrome (RR of 1.18), and mixed CTD (RR of 1.18). Patients whose onset of RP occurred past 40 years of age and those with worsening RP attacks were at risk for the future development of CTD.

Entities:  

Mesh:

Year:  2012        PMID: 22821334     DOI: 10.1007/s00296-012-2484-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  31 in total

Review 1.  Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria.

Authors:  M Mosca; R Neri; S Bombardieri
Journal:  Clin Exp Rheumatol       Date:  1999 Sep-Oct       Impact factor: 4.473

2.  Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon.

Authors:  Madeleine Meli; Gabriela Gitzelmann; Renate Koppensteiner; Beatrice R Amann-Vesti
Journal:  Clin Rheumatol       Date:  2005-06-11       Impact factor: 2.980

3.  The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease.

Authors:  T Ohtsuka; T Tamura; A Yamakage; S Yamazaki
Journal:  Br J Dermatol       Date:  1998-10       Impact factor: 9.302

4.  Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.

Authors:  H R Maricq; P H Carpentier; M C Weinrich; J E Keil; Y Palesch; C Biro; M Vionnet-Fuasset; M Jiguet; I Valter
Journal:  J Rheumatol       Date:  1997-05       Impact factor: 4.666

5.  Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire.

Authors:  H R Maricq; M C Weinrich; J E Keil; E C LeRoy
Journal:  J Chronic Dis       Date:  1986

6.  Prevalence of symptoms of Raynaud's phenomenon in general practice.

Authors:  A Silman; S Holligan; P Brennan; P Maddison
Journal:  BMJ       Date:  1990-09-22

7.  Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon.

Authors:  Slavica Pavlov-Dolijanovic; Nemanja S Damjanov; Roksanda M Stojanovic; Nada Z Vujasinovic Stupar; Dejana M Stanisavljevic
Journal:  Rheumatol Int       Date:  2011-09-08       Impact factor: 2.631

8.  Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases.

Authors:  G Spencer-Green
Journal:  Arch Intern Med       Date:  1998-03-23

9.  Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.

Authors:  D Alarcón-Segovia; M H Cardiel
Journal:  J Rheumatol       Date:  1989-03       Impact factor: 4.666

Review 10.  Raynaud's phenomenon: a proposal for classification.

Authors:  E C LeRoy; T A Medsger
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

View more
  3 in total

1.  Diagnosis of Raynaud's phenomenon by 99mTc-pertechnetate hand perfusion scintigraphy: a pilot study.

Authors:  Slavica Pavlov-Dolijanovic; Nebojsa Petrovic; Nada Vujasinovic Stupar; Nemanja Damjanov; Goran Radunovic; Dragan Babic; Dragana Sobic-Saranovic; Vera Artiko
Journal:  Rheumatol Int       Date:  2016-10-25       Impact factor: 2.631

2.  Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.

Authors:  Hèctor Corominas; Vera Ortiz-Santamaría; Iván Castellví; Mireia Moreno; Rosa Morlà; Teresa Clavaguera; Alba Erra; Silvia Martínez-Pardo; Sergi Ordóñez; Pilar Santo; Patricia Reyner; Maria José González; Oriol Codina; Mario Saul Gelman; Xavier Juanola-Roura; Alex Olivé; Vicenç Torrente-Segarra
Journal:  Rheumatol Int       Date:  2015-11-23       Impact factor: 2.631

3.  Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon.

Authors:  Francesca Ingegnoli; Roberta Gualtierotti; Annalisa Orenti; Tommaso Schioppo; Giovanni Marfia; Rolando Campanella; Claudio Mastaglio; Pier Luigi Meroni; Patrizia Boracchi
Journal:  J Immunol Res       Date:  2015-05-17       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.